跳至主要内容
临床试验/CTRI/2021/02/031258
CTRI/2021/02/031258招募中未知

: Median effective dose of intranasal dexmedetomidine for satisfactory mask induction in children undergoing examination under anaesthesia for retinoblastoma- an up and down sequential allocation study

arayana Nethralaya0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
未知
状态
招募中
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 40 ASA I-III children with known or suspected retinoblastoma aged 1-60 months undergoing EUA ± focal therapy

排除标准

  • The exclusion criteria are lack of parental consent, known allergy to dexmedtomidine, nasal discharge, renal or hepatic dysfunction, any serious systemic diseases

研究者

发起方
arayana Nethralaya

相似试验